Home   Chapter Home   Jobs   Conferences   Fellowships   Books



Advertisement

CD Markers

CD9


Reviewers: Nat Pernick, M.D., (see Reviewers page)
Revised: 18 December 2010, last major update December 2010
Copyright: (c) 2002-2010, PathologyOutlines.com, Inc.

General
=========================================================================

● Cell surface protein that mediates various signal transduction events

Terminology
=========================================================================

● Also called motility related protein 1 (MRP1)

Physiology
=========================================================================

● Member of transmembrane 4 superfamily (tetraspanin family); tetraspanins have 4 hydrophobic domains, organize multimolecular complexes in the plasma membrane; each tetraspanin associates specifically with integrins and other tetraspanins, forming primary complexes and leading to a molecular network of interactions, the "tetraspanin web"
● Regulates cell motility, development, activation, growth and adhesion (Blood 2010 Nov 9 [Epub ahead of print])
● Regulates paranodal junction formation (between neurons and glia)
● Oocyte CD9 is required for sperm-egg fusion
● Required for microparticle release from coated-platelets (Platelets 2009;20:361); triggers platelet activation and aggregation
● Supports myotube maintenance and promotes muscle cell fusion

Diagrams
=========================================================================

Structure

Clinical features
=========================================================================

● Antibodies are used to purge bone marrow in acute lymphoblastic leukemia prior to peripheral stem cell bone marrow transplant (Am J Pediatr Hematol Oncol 1993;15:162)
● Downregulation in ovarian carcinoma may promote tumor dissemination (Cancer Res 2005;65:2617)
● Presence in small cell lung cancer may mediate chemoresistance (Cancer Res 2010;70:8025)
● Expression is associated with poor prognosis in gastric carcinoma (Pathol Res Pract 2010;206:607)

Uses by pathologists
=========================================================================

● No significant clinical use by pathologists

Micro images
=========================================================================


Normal tissue

Vascular endothelium

Cervical squamous epithelium

Normal cerebrum

Various tumors

Cervical carcinoma

       

Various CNS non-neuroepithelial tumors


Various images

Positive staining (normal)
=========================================================================

● Pre B cells, B cell subset, activated T cells, basophils, eosinophils, macrophages, megakaryocytes, plasma cells, platelets
● Brain, cardiac muscle, GI system, kidney (glomeruli, tubules and collective ducts), liver, lymphatic epithelium, ovarian surface epithelium, peripheral nerve, skin, spleen, thyroid, tonsil

Positive staining (disease)
=========================================================================

● Pre-B ALL, AML-M3, astrocytoma (J Histochem Cytochem 2002;50:1195)
● Vascular tumors: angiosarcoma, juvenile nasopharyngeal angiofibroma, Kaposi’s sarcoma (Mod Path 2003;16:1028)

Negative staining
=========================================================================

● Red blood cells, renal collecting duct carcinomas (almost all)

Additional references
=========================================================================

MIM 143030

End of CD Markers > CD9


This information is intended for physicians and related personnel, who understand that medical information is often imperfect, and must be interpreted in the context of a patient's clinical data using reasonable medical judgment. This website should not be used as a substitute for the advice of a licensed physician.

All information on this website is protected by copyright of PathologyOutlines.com, Inc. Information from third parties may also be protected by copyright. Please contact us at copyrightPathOut@gmail.com with any questions (click here for other contact information).